nodes	percent_of_prediction	percent_of_DWPC	metapath
Irinotecan—colon cancer—breast cancer	0.215	1	CtDrD
Irinotecan—Topoisomerase Inhibitors—Idarubicin—breast cancer	0.135	0.366	CiPCiCtD
Irinotecan—Topoisomerase Inhibitors—Mitoxantrone—breast cancer	0.115	0.311	CiPCiCtD
Irinotecan—Topoisomerase Inhibitors—Epirubicin—breast cancer	0.062	0.168	CiPCiCtD
Irinotecan—Topoisomerase Inhibitors—Doxorubicin—breast cancer	0.0574	0.155	CiPCiCtD
Irinotecan—SLCO1B1—breast cancer	0.0384	0.244	CbGaD
Irinotecan—ABCC1—breast cancer	0.0317	0.201	CbGaD
Irinotecan—ACHE—breast cancer	0.0302	0.192	CbGaD
Irinotecan—BCHE—breast cancer	0.0178	0.113	CbGaD
Irinotecan—ABCG2—breast cancer	0.0167	0.106	CbGaD
Irinotecan—SLC22A3—Melphalan—breast cancer	0.0145	0.0934	CbGbCtD
Irinotecan—CES1—Capecitabine—breast cancer	0.0127	0.0819	CbGbCtD
Irinotecan—CES1—Tamoxifen—breast cancer	0.0102	0.0659	CbGbCtD
Irinotecan—ABCC1—Idarubicin—breast cancer	0.00945	0.061	CbGbCtD
Irinotecan—CYP3A4—breast cancer	0.00836	0.0531	CbGaD
Irinotecan—ALB—breast cancer	0.00729	0.0463	CbGaD
Irinotecan—ABCB1—breast cancer	0.00696	0.0442	CbGaD
Irinotecan—CYP2B6—Thiotepa—breast cancer	0.00445	0.0287	CbGbCtD
Irinotecan—ABCC1—Mitoxantrone—breast cancer	0.00406	0.0262	CbGbCtD
Irinotecan—ABCC1—Epirubicin—breast cancer	0.00329	0.0212	CbGbCtD
Irinotecan—ABCC1—Paclitaxel—breast cancer	0.00324	0.0209	CbGbCtD
Irinotecan—CYP3A5—Lapatinib—breast cancer	0.00308	0.0199	CbGbCtD
Irinotecan—ABCC2—Tamoxifen—breast cancer	0.00308	0.0199	CbGbCtD
Irinotecan—CYP2B6—Raloxifene—breast cancer	0.00297	0.0191	CbGbCtD
Irinotecan—ABCC1—Vinblastine—breast cancer	0.00284	0.0183	CbGbCtD
Irinotecan—ABCG2—Tamoxifen—breast cancer	0.00279	0.018	CbGbCtD
Irinotecan—ABCB1—Toremifene—breast cancer	0.00275	0.0178	CbGbCtD
Irinotecan—ABCG2—Mitoxantrone—breast cancer	0.00272	0.0175	CbGbCtD
Irinotecan—ABCC2—Paclitaxel—breast cancer	0.0024	0.0155	CbGbCtD
Irinotecan—CYP3A4—Exemestane—breast cancer	0.00238	0.0153	CbGbCtD
Irinotecan—ABCC1—Docetaxel—breast cancer	0.00234	0.0151	CbGbCtD
Irinotecan—ABCC2—Carboplatin—breast cancer	0.00226	0.0146	CbGbCtD
Irinotecan—ABCG2—Paclitaxel—breast cancer	0.00217	0.014	CbGbCtD
Irinotecan—ABCC2—Vinblastine—breast cancer	0.00211	0.0136	CbGbCtD
Irinotecan—CYP3A7—Tamoxifen—breast cancer	0.00206	0.0133	CbGbCtD
Irinotecan—CYP3A7-CYP3A51P—Tamoxifen—breast cancer	0.00206	0.0133	CbGbCtD
Irinotecan—ABCG2—Fluorouracil—breast cancer	0.00205	0.0133	CbGbCtD
Irinotecan—ABCG2—Carboplatin—breast cancer	0.00204	0.0132	CbGbCtD
Irinotecan—CYP3A4—Letrozole—breast cancer	0.00202	0.013	CbGbCtD
Irinotecan—ABCB1—Lapatinib—breast cancer	0.00201	0.013	CbGbCtD
Irinotecan—CYP2B6—Tamoxifen—breast cancer	0.00196	0.0126	CbGbCtD
Irinotecan—CYP3A4—Anastrozole—breast cancer	0.0018	0.0116	CbGbCtD
Irinotecan—ABCC1—Doxorubicin—breast cancer	0.00175	0.0113	CbGbCtD
Irinotecan—ABCC2—Docetaxel—breast cancer	0.00174	0.0112	CbGbCtD
Irinotecan—ABCC1—Methotrexate—breast cancer	0.00169	0.0109	CbGbCtD
Irinotecan—CYP3A4—Toremifene—breast cancer	0.00165	0.0106	CbGbCtD
Irinotecan—CYP3A7—Paclitaxel—breast cancer	0.0016	0.0103	CbGbCtD
Irinotecan—CYP3A7-CYP3A51P—Paclitaxel—breast cancer	0.0016	0.0103	CbGbCtD
Irinotecan—ABCG2—Docetaxel—breast cancer	0.00157	0.0101	CbGbCtD
Irinotecan—CYP3A5—Tamoxifen—breast cancer	0.00154	0.00996	CbGbCtD
Irinotecan—CYP3A4—Fulvestrant—breast cancer	0.00153	0.00989	CbGbCtD
Irinotecan—SLCO1B1—Methotrexate—breast cancer	0.00143	0.0092	CbGbCtD
Irinotecan—ALB—Fluorouracil—breast cancer	0.00142	0.00914	CbGbCtD
Irinotecan—CYP3A4—Thiotepa—breast cancer	0.00137	0.00881	CbGbCtD
Irinotecan—ABCC2—Doxorubicin—breast cancer	0.00129	0.00834	CbGbCtD
Irinotecan—ABCC2—Methotrexate—breast cancer	0.00125	0.00808	CbGbCtD
Irinotecan—CYP3A4—Ixabepilone—breast cancer	0.00125	0.00806	CbGbCtD
Irinotecan—CYP3A4—Lapatinib—breast cancer	0.0012	0.00776	CbGbCtD
Irinotecan—CYP3A5—Paclitaxel—breast cancer	0.0012	0.00776	CbGbCtD
Irinotecan—ABCG2—Doxorubicin—breast cancer	0.00117	0.00754	CbGbCtD
Irinotecan—CYP3A7-CYP3A51P—Docetaxel—breast cancer	0.00116	0.00747	CbGbCtD
Irinotecan—CYP3A7—Docetaxel—breast cancer	0.00116	0.00747	CbGbCtD
Irinotecan—ABCG2—Methotrexate—breast cancer	0.00113	0.00731	CbGbCtD
Irinotecan—ABCB1—Vinorelbine—breast cancer	0.00111	0.00718	CbGbCtD
Irinotecan—ABCB1—Tamoxifen—breast cancer	0.00101	0.00648	CbGbCtD
Irinotecan—ABCB1—Mitoxantrone—breast cancer	0.00098	0.00632	CbGbCtD
Irinotecan—CYP3A4—Raloxifene—breast cancer	0.000912	0.00588	CbGbCtD
Irinotecan—CYP3A5—Docetaxel—breast cancer	0.000869	0.00561	CbGbCtD
Irinotecan—ABCB1—Gemcitabine—breast cancer	0.000866	0.00559	CbGbCtD
Irinotecan—CYP2B6—Doxorubicin—breast cancer	0.000822	0.00531	CbGbCtD
Irinotecan—ABCB1—Paclitaxel—breast cancer	0.000782	0.00505	CbGbCtD
Irinotecan—ALB—Methotrexate—breast cancer	0.000781	0.00504	CbGbCtD
Irinotecan—ABCB1—Vinblastine—breast cancer	0.000686	0.00443	CbGbCtD
Irinotecan—CYP3A4—Vinorelbine—breast cancer	0.000667	0.0043	CbGbCtD
Irinotecan—CYP3A4—Tamoxifen—breast cancer	0.000602	0.00389	CbGbCtD
Irinotecan—CYP3A4—Mitoxantrone—breast cancer	0.000587	0.00379	CbGbCtD
Irinotecan—ABCB1—Docetaxel—breast cancer	0.000566	0.00365	CbGbCtD
Irinotecan—CYP3A4—Paclitaxel—breast cancer	0.000469	0.00302	CbGbCtD
Irinotecan—Topotecan—ABCG2—breast cancer	0.000468	0.522	CrCbGaD
Irinotecan—TOP1—mammary gland—breast cancer	0.000448	0.0336	CbGeAlD
Irinotecan—ABCB1—Doxorubicin—breast cancer	0.000422	0.00272	CbGbCtD
Irinotecan—CYP3A4—Vinblastine—breast cancer	0.000411	0.00265	CbGbCtD
Irinotecan—ABCB1—Methotrexate—breast cancer	0.000408	0.00264	CbGbCtD
Irinotecan—CES2—mammary gland—breast cancer	0.000406	0.0304	CbGeAlD
Irinotecan—TOP1MT—adipose tissue—breast cancer	0.000382	0.0286	CbGeAlD
Irinotecan—TOP1—nipple—breast cancer	0.000371	0.0278	CbGeAlD
Irinotecan—TOP1MT—female reproductive system—breast cancer	0.000351	0.0263	CbGeAlD
Irinotecan—TOP1MT—adrenal gland—breast cancer	0.000343	0.0257	CbGeAlD
Irinotecan—CYP3A4—Docetaxel—breast cancer	0.000339	0.00219	CbGbCtD
Irinotecan—CES2—nipple—breast cancer	0.000336	0.0252	CbGeAlD
Irinotecan—TOP1MT—female gonad—breast cancer	0.00032	0.0239	CbGeAlD
Irinotecan—TOP1MT—endocrine gland—breast cancer	0.000297	0.0223	CbGeAlD
Irinotecan—SLCO1B1—mammary gland—breast cancer	0.000287	0.0215	CbGeAlD
Irinotecan—CYP3A4—Doxorubicin—breast cancer	0.000253	0.00163	CbGbCtD
Irinotecan—Topotecan—CYP3A4—breast cancer	0.000234	0.261	CrCbGaD
Irinotecan—ALB—mammary gland—breast cancer	0.000233	0.0174	CbGeAlD
Irinotecan—TOP1—endometrium—breast cancer	0.000224	0.0168	CbGeAlD
Irinotecan—CES2—skin of body—breast cancer	0.000215	0.0161	CbGeAlD
Irinotecan—TOP1—uterus—breast cancer	0.000206	0.0154	CbGeAlD
Irinotecan—TOP1MT—lymph node—breast cancer	0.000206	0.0154	CbGeAlD
Irinotecan—CES2—endometrium—breast cancer	0.000203	0.0152	CbGeAlD
Irinotecan—TOP1—pituitary gland—breast cancer	0.000202	0.0152	CbGeAlD
Irinotecan—TOP1—adipose tissue—breast cancer	0.000202	0.0151	CbGeAlD
Irinotecan—Topotecan—ABCB1—breast cancer	0.000195	0.217	CrCbGaD
Irinotecan—SLC22A3—nipple—breast cancer	0.000192	0.0144	CbGeAlD
Irinotecan—CES2—uterus—breast cancer	0.000187	0.014	CbGeAlD
Irinotecan—CES2—pituitary gland—breast cancer	0.000184	0.0138	CbGeAlD
Irinotecan—CES2—adipose tissue—breast cancer	0.000183	0.0137	CbGeAlD
Irinotecan—TOP1—adrenal gland—breast cancer	0.000181	0.0135	CbGeAlD
Irinotecan—UGT1A9—endocrine gland—breast cancer	0.000176	0.0132	CbGeAlD
Irinotecan—TOP1—bone marrow—breast cancer	0.000175	0.0131	CbGeAlD
Irinotecan—TOP1—female gonad—breast cancer	0.000169	0.0126	CbGeAlD
Irinotecan—CES2—female reproductive system—breast cancer	0.000168	0.0126	CbGeAlD
Irinotecan—CES2—adrenal gland—breast cancer	0.000164	0.0123	CbGeAlD
Irinotecan—ABCC1—nipple—breast cancer	0.000159	0.0119	CbGeAlD
Irinotecan—CES2—bone marrow—breast cancer	0.000159	0.0119	CbGeAlD
Irinotecan—SLC22A3—embryo—breast cancer	0.000158	0.0119	CbGeAlD
Irinotecan—CES2—female gonad—breast cancer	0.000153	0.0115	CbGeAlD
Irinotecan—CES1—adipose tissue—breast cancer	0.000151	0.0113	CbGeAlD
Irinotecan—CYP3A7—endocrine gland—breast cancer	0.000147	0.011	CbGeAlD
Irinotecan—CES2—endocrine gland—breast cancer	0.000142	0.0107	CbGeAlD
Irinotecan—CES1—female reproductive system—breast cancer	0.000138	0.0104	CbGeAlD
Irinotecan—BCHE—nipple—breast cancer	0.000136	0.0102	CbGeAlD
Irinotecan—CES1—adrenal gland—breast cancer	0.000135	0.0101	CbGeAlD
Irinotecan—ACHE—adrenal gland—breast cancer	0.000135	0.0101	CbGeAlD
Irinotecan—CES1—female gonad—breast cancer	0.000126	0.00943	CbGeAlD
Irinotecan—UGT1A1—endocrine gland—breast cancer	0.000121	0.00906	CbGeAlD
Irinotecan—SLCO1B1—female reproductive system—breast cancer	0.000119	0.00891	CbGeAlD
Irinotecan—CES1—endocrine gland—breast cancer	0.000117	0.00877	CbGeAlD
Irinotecan—SLC22A3—endometrium—breast cancer	0.000116	0.00869	CbGeAlD
Irinotecan—TOP1—lymph node—breast cancer	0.000108	0.00812	CbGeAlD
Irinotecan—SLC22A3—adipose tissue—breast cancer	0.000105	0.00783	CbGeAlD
Irinotecan—SLCO1B1—endocrine gland—breast cancer	0.000101	0.00754	CbGeAlD
Irinotecan—CES2—lymph node—breast cancer	9.83e-05	0.00736	CbGeAlD
Irinotecan—SLC22A3—female reproductive system—breast cancer	9.61e-05	0.00719	CbGeAlD
Irinotecan—ABCC1—endometrium—breast cancer	9.59e-05	0.00718	CbGeAlD
Irinotecan—ALB—adrenal gland—breast cancer	9.39e-05	0.00703	CbGeAlD
Irinotecan—SLC22A3—adrenal gland—breast cancer	9.37e-05	0.00702	CbGeAlD
Irinotecan—ABCC2—female reproductive system—breast cancer	9.02e-05	0.00675	CbGeAlD
Irinotecan—ABCC1—uterus—breast cancer	8.83e-05	0.00662	CbGeAlD
Irinotecan—ABCC2—adrenal gland—breast cancer	8.8e-05	0.00659	CbGeAlD
Irinotecan—SLC22A3—female gonad—breast cancer	8.74e-05	0.00655	CbGeAlD
Irinotecan—BCHE—skin of body—breast cancer	8.71e-05	0.00652	CbGeAlD
Irinotecan—ABCC1—pituitary gland—breast cancer	8.68e-05	0.0065	CbGeAlD
Irinotecan—ABCC1—adipose tissue—breast cancer	8.64e-05	0.00647	CbGeAlD
Irinotecan—BCHE—endometrium—breast cancer	8.21e-05	0.00615	CbGeAlD
Irinotecan—SLC22A3—endocrine gland—breast cancer	8.13e-05	0.00609	CbGeAlD
Irinotecan—ACHE—lymph node—breast cancer	8.1e-05	0.00606	CbGeAlD
Irinotecan—CES1—lymph node—breast cancer	8.1e-05	0.00606	CbGeAlD
Irinotecan—ABCG2—endometrium—breast cancer	7.94e-05	0.00594	CbGeAlD
Irinotecan—CYP2B6—skin of body—breast cancer	7.77e-05	0.00582	CbGeAlD
Irinotecan—ABCC1—adrenal gland—breast cancer	7.75e-05	0.0058	CbGeAlD
Irinotecan—ABCC2—endocrine gland—breast cancer	7.63e-05	0.00571	CbGeAlD
Irinotecan—BCHE—uterus—breast cancer	7.57e-05	0.00567	CbGeAlD
Irinotecan—BCHE—pituitary gland—breast cancer	7.43e-05	0.00557	CbGeAlD
Irinotecan—BCHE—adipose tissue—breast cancer	7.4e-05	0.00554	CbGeAlD
Irinotecan—ABCG2—uterus—breast cancer	7.31e-05	0.00548	CbGeAlD
Irinotecan—ABCC1—female gonad—breast cancer	7.23e-05	0.00541	CbGeAlD
Irinotecan—ABCG2—pituitary gland—breast cancer	7.18e-05	0.00538	CbGeAlD
Irinotecan—ABCG2—adipose tissue—breast cancer	7.15e-05	0.00536	CbGeAlD
Irinotecan—BCHE—female reproductive system—breast cancer	6.8e-05	0.0051	CbGeAlD
Irinotecan—CYP3A5—adipose tissue—breast cancer	6.64e-05	0.00497	CbGeAlD
Irinotecan—BCHE—adrenal gland—breast cancer	6.64e-05	0.00497	CbGeAlD
Irinotecan—BCHE—bone marrow—breast cancer	6.42e-05	0.00481	CbGeAlD
Irinotecan—ABCG2—adrenal gland—breast cancer	6.42e-05	0.00481	CbGeAlD
Irinotecan—ABCG2—bone marrow—breast cancer	6.21e-05	0.00465	CbGeAlD
Irinotecan—CYP2B6—female reproductive system—breast cancer	6.07e-05	0.00454	CbGeAlD
Irinotecan—ABCG2—female gonad—breast cancer	5.98e-05	0.00448	CbGeAlD
Irinotecan—CYP2B6—adrenal gland—breast cancer	5.92e-05	0.00443	CbGeAlD
Irinotecan—BCHE—endocrine gland—breast cancer	5.76e-05	0.00431	CbGeAlD
Irinotecan—ALB—lymph node—breast cancer	5.63e-05	0.00422	CbGeAlD
Irinotecan—SLC22A3—lymph node—breast cancer	5.62e-05	0.00421	CbGeAlD
Irinotecan—CYP3A5—female gonad—breast cancer	5.55e-05	0.00416	CbGeAlD
Irinotecan—ABCB1—embryo—breast cancer	5.35e-05	0.00401	CbGeAlD
Irinotecan—ABCC2—lymph node—breast cancer	5.27e-05	0.00395	CbGeAlD
Irinotecan—CYP3A5—endocrine gland—breast cancer	5.16e-05	0.00387	CbGeAlD
Irinotecan—CYP2B6—endocrine gland—breast cancer	5.13e-05	0.00384	CbGeAlD
Irinotecan—ABCC1—lymph node—breast cancer	4.65e-05	0.00348	CbGeAlD
Irinotecan—CYP3A4—female reproductive system—breast cancer	4.58e-05	0.00343	CbGeAlD
Irinotecan—ABCB1—epithelium—breast cancer	4.36e-05	0.00327	CbGeAlD
Irinotecan—BCHE—lymph node—breast cancer	3.98e-05	0.00298	CbGeAlD
Irinotecan—ABCB1—endometrium—breast cancer	3.91e-05	0.00293	CbGeAlD
Irinotecan—CYP3A4—endocrine gland—breast cancer	3.88e-05	0.0029	CbGeAlD
Irinotecan—ABCG2—lymph node—breast cancer	3.85e-05	0.00288	CbGeAlD
Irinotecan—ABCB1—uterus—breast cancer	3.61e-05	0.0027	CbGeAlD
Irinotecan—ABCB1—pituitary gland—breast cancer	3.54e-05	0.00265	CbGeAlD
Irinotecan—ABCB1—adipose tissue—breast cancer	3.53e-05	0.00264	CbGeAlD
Irinotecan—ABCB1—female reproductive system—breast cancer	3.24e-05	0.00243	CbGeAlD
Irinotecan—ABCB1—adrenal gland—breast cancer	3.16e-05	0.00237	CbGeAlD
Irinotecan—ABCB1—bone marrow—breast cancer	3.06e-05	0.00229	CbGeAlD
Irinotecan—ABCB1—female gonad—breast cancer	2.95e-05	0.00221	CbGeAlD
Irinotecan—ABCB1—endocrine gland—breast cancer	2.74e-05	0.00205	CbGeAlD
Irinotecan—ABCB1—lymph node—breast cancer	1.9e-05	0.00142	CbGeAlD
Irinotecan—Diarrhoea—Gemcitabine—breast cancer	8.38e-06	0.000153	CcSEcCtD
Irinotecan—Renal failure—Doxorubicin—breast cancer	8.36e-06	0.000153	CcSEcCtD
Irinotecan—Infection—Capecitabine—breast cancer	8.36e-06	0.000153	CcSEcCtD
Irinotecan—Haemoglobin—Epirubicin—breast cancer	8.29e-06	0.000152	CcSEcCtD
Irinotecan—Stomatitis—Doxorubicin—breast cancer	8.29e-06	0.000152	CcSEcCtD
Irinotecan—Jaundice—Doxorubicin—breast cancer	8.29e-06	0.000152	CcSEcCtD
Irinotecan—Anorexia—Docetaxel—breast cancer	8.28e-06	0.000152	CcSEcCtD
Irinotecan—Shock—Capecitabine—breast cancer	8.28e-06	0.000152	CcSEcCtD
Irinotecan—Rhinitis—Epirubicin—breast cancer	8.27e-06	0.000151	CcSEcCtD
Irinotecan—Nervous system disorder—Capecitabine—breast cancer	8.25e-06	0.000151	CcSEcCtD
Irinotecan—Haemorrhage—Epirubicin—breast cancer	8.25e-06	0.000151	CcSEcCtD
Irinotecan—Diarrhoea—Fluorouracil—breast cancer	8.24e-06	0.000151	CcSEcCtD
Irinotecan—Thrombocytopenia—Capecitabine—breast cancer	8.24e-06	0.000151	CcSEcCtD
Irinotecan—Cardiac disorder—Methotrexate—breast cancer	8.18e-06	0.00015	CcSEcCtD
Irinotecan—Sweating—Doxorubicin—breast cancer	8.15e-06	0.000149	CcSEcCtD
Irinotecan—Hyperhidrosis—Capecitabine—breast cancer	8.13e-06	0.000149	CcSEcCtD
Irinotecan—Hypotension—Docetaxel—breast cancer	8.12e-06	0.000149	CcSEcCtD
Irinotecan—Connective tissue disorder—Epirubicin—breast cancer	8.11e-06	0.000148	CcSEcCtD
Irinotecan—Abdominal pain—Paclitaxel—breast cancer	8.1e-06	0.000148	CcSEcCtD
Irinotecan—Body temperature increased—Paclitaxel—breast cancer	8.1e-06	0.000148	CcSEcCtD
Irinotecan—Anorexia—Capecitabine—breast cancer	8.02e-06	0.000147	CcSEcCtD
Irinotecan—Angiopathy—Methotrexate—breast cancer	8e-06	0.000146	CcSEcCtD
Irinotecan—Vomiting—Mitoxantrone—breast cancer	7.99e-06	0.000146	CcSEcCtD
Irinotecan—Immune system disorder—Methotrexate—breast cancer	7.96e-06	0.000146	CcSEcCtD
Irinotecan—Dizziness—Fluorouracil—breast cancer	7.96e-06	0.000146	CcSEcCtD
Irinotecan—Visual impairment—Epirubicin—breast cancer	7.95e-06	0.000146	CcSEcCtD
Irinotecan—Mediastinal disorder—Methotrexate—breast cancer	7.95e-06	0.000145	CcSEcCtD
Irinotecan—Rash—Mitoxantrone—breast cancer	7.93e-06	0.000145	CcSEcCtD
Irinotecan—Dermatitis—Mitoxantrone—breast cancer	7.92e-06	0.000145	CcSEcCtD
Irinotecan—Chills—Methotrexate—breast cancer	7.91e-06	0.000145	CcSEcCtD
Irinotecan—Headache—Mitoxantrone—breast cancer	7.88e-06	0.000144	CcSEcCtD
Irinotecan—Hypotension—Capecitabine—breast cancer	7.86e-06	0.000144	CcSEcCtD
Irinotecan—Insomnia—Docetaxel—breast cancer	7.86e-06	0.000144	CcSEcCtD
Irinotecan—Paraesthesia—Docetaxel—breast cancer	7.8e-06	0.000143	CcSEcCtD
Irinotecan—Alopecia—Methotrexate—breast cancer	7.79e-06	0.000143	CcSEcCtD
Irinotecan—Vomiting—Gemcitabine—breast cancer	7.79e-06	0.000143	CcSEcCtD
Irinotecan—Bradycardia—Doxorubicin—breast cancer	7.77e-06	0.000142	CcSEcCtD
Irinotecan—Dyspnoea—Docetaxel—breast cancer	7.75e-06	0.000142	CcSEcCtD
Irinotecan—Somnolence—Docetaxel—breast cancer	7.73e-06	0.000141	CcSEcCtD
Irinotecan—Rash—Gemcitabine—breast cancer	7.72e-06	0.000141	CcSEcCtD
Irinotecan—Dermatitis—Gemcitabine—breast cancer	7.71e-06	0.000141	CcSEcCtD
Irinotecan—Haemoglobin—Doxorubicin—breast cancer	7.67e-06	0.00014	CcSEcCtD
Irinotecan—Headache—Gemcitabine—breast cancer	7.67e-06	0.00014	CcSEcCtD
Irinotecan—Cardiac disorder—Epirubicin—breast cancer	7.66e-06	0.00014	CcSEcCtD
Irinotecan—Flushing—Epirubicin—breast cancer	7.66e-06	0.00014	CcSEcCtD
Irinotecan—Vomiting—Fluorouracil—breast cancer	7.66e-06	0.00014	CcSEcCtD
Irinotecan—Rhinitis—Doxorubicin—breast cancer	7.65e-06	0.00014	CcSEcCtD
Irinotecan—Dyspepsia—Docetaxel—breast cancer	7.65e-06	0.00014	CcSEcCtD
Irinotecan—Haemorrhage—Doxorubicin—breast cancer	7.63e-06	0.00014	CcSEcCtD
Irinotecan—Insomnia—Capecitabine—breast cancer	7.61e-06	0.000139	CcSEcCtD
Irinotecan—Rash—Fluorouracil—breast cancer	7.59e-06	0.000139	CcSEcCtD
Irinotecan—Dermatitis—Fluorouracil—breast cancer	7.58e-06	0.000139	CcSEcCtD
Irinotecan—Paraesthesia—Capecitabine—breast cancer	7.56e-06	0.000138	CcSEcCtD
Irinotecan—Decreased appetite—Docetaxel—breast cancer	7.55e-06	0.000138	CcSEcCtD
Irinotecan—Hypersensitivity—Paclitaxel—breast cancer	7.55e-06	0.000138	CcSEcCtD
Irinotecan—Headache—Fluorouracil—breast cancer	7.54e-06	0.000138	CcSEcCtD
Irinotecan—Gastrointestinal disorder—Docetaxel—breast cancer	7.5e-06	0.000137	CcSEcCtD
Irinotecan—Connective tissue disorder—Doxorubicin—breast cancer	7.5e-06	0.000137	CcSEcCtD
Irinotecan—Dyspnoea—Capecitabine—breast cancer	7.5e-06	0.000137	CcSEcCtD
Irinotecan—Fatigue—Docetaxel—breast cancer	7.49e-06	0.000137	CcSEcCtD
Irinotecan—Angiopathy—Epirubicin—breast cancer	7.49e-06	0.000137	CcSEcCtD
Irinotecan—Nausea—Mitoxantrone—breast cancer	7.47e-06	0.000137	CcSEcCtD
Irinotecan—Immune system disorder—Epirubicin—breast cancer	7.45e-06	0.000136	CcSEcCtD
Irinotecan—Mediastinal disorder—Epirubicin—breast cancer	7.44e-06	0.000136	CcSEcCtD
Irinotecan—Pain—Docetaxel—breast cancer	7.43e-06	0.000136	CcSEcCtD
Irinotecan—Constipation—Docetaxel—breast cancer	7.43e-06	0.000136	CcSEcCtD
Irinotecan—Back pain—Methotrexate—breast cancer	7.42e-06	0.000136	CcSEcCtD
Irinotecan—Dyspepsia—Capecitabine—breast cancer	7.41e-06	0.000136	CcSEcCtD
Irinotecan—Chills—Epirubicin—breast cancer	7.4e-06	0.000136	CcSEcCtD
Irinotecan—Arrhythmia—Epirubicin—breast cancer	7.37e-06	0.000135	CcSEcCtD
Irinotecan—Visual impairment—Doxorubicin—breast cancer	7.36e-06	0.000135	CcSEcCtD
Irinotecan—Asthenia—Paclitaxel—breast cancer	7.36e-06	0.000135	CcSEcCtD
Irinotecan—Decreased appetite—Capecitabine—breast cancer	7.31e-06	0.000134	CcSEcCtD
Irinotecan—Alopecia—Epirubicin—breast cancer	7.29e-06	0.000133	CcSEcCtD
Irinotecan—Nausea—Gemcitabine—breast cancer	7.27e-06	0.000133	CcSEcCtD
Irinotecan—Gastrointestinal disorder—Capecitabine—breast cancer	7.26e-06	0.000133	CcSEcCtD
Irinotecan—Fatigue—Capecitabine—breast cancer	7.25e-06	0.000133	CcSEcCtD
Irinotecan—Pain—Capecitabine—breast cancer	7.19e-06	0.000132	CcSEcCtD
Irinotecan—Constipation—Capecitabine—breast cancer	7.19e-06	0.000132	CcSEcCtD
Irinotecan—Feeling abnormal—Docetaxel—breast cancer	7.16e-06	0.000131	CcSEcCtD
Irinotecan—Nausea—Fluorouracil—breast cancer	7.15e-06	0.000131	CcSEcCtD
Irinotecan—Ill-defined disorder—Methotrexate—breast cancer	7.12e-06	0.00013	CcSEcCtD
Irinotecan—Gastrointestinal pain—Docetaxel—breast cancer	7.11e-06	0.00013	CcSEcCtD
Irinotecan—Anaemia—Methotrexate—breast cancer	7.09e-06	0.00013	CcSEcCtD
Irinotecan—Cardiac disorder—Doxorubicin—breast cancer	7.08e-06	0.00013	CcSEcCtD
Irinotecan—Flushing—Doxorubicin—breast cancer	7.08e-06	0.00013	CcSEcCtD
Irinotecan—Flatulence—Epirubicin—breast cancer	7.08e-06	0.00013	CcSEcCtD
Irinotecan—Diarrhoea—Paclitaxel—breast cancer	7.01e-06	0.000128	CcSEcCtD
Irinotecan—Back pain—Epirubicin—breast cancer	6.95e-06	0.000127	CcSEcCtD
Irinotecan—Feeling abnormal—Capecitabine—breast cancer	6.93e-06	0.000127	CcSEcCtD
Irinotecan—Angiopathy—Doxorubicin—breast cancer	6.93e-06	0.000127	CcSEcCtD
Irinotecan—Malaise—Methotrexate—breast cancer	6.92e-06	0.000127	CcSEcCtD
Irinotecan—Muscle spasms—Epirubicin—breast cancer	6.91e-06	0.000126	CcSEcCtD
Irinotecan—Immune system disorder—Doxorubicin—breast cancer	6.9e-06	0.000126	CcSEcCtD
Irinotecan—Vertigo—Methotrexate—breast cancer	6.9e-06	0.000126	CcSEcCtD
Irinotecan—Gastrointestinal pain—Capecitabine—breast cancer	6.88e-06	0.000126	CcSEcCtD
Irinotecan—Mediastinal disorder—Doxorubicin—breast cancer	6.88e-06	0.000126	CcSEcCtD
Irinotecan—Abdominal pain—Docetaxel—breast cancer	6.87e-06	0.000126	CcSEcCtD
Irinotecan—Body temperature increased—Docetaxel—breast cancer	6.87e-06	0.000126	CcSEcCtD
Irinotecan—Leukopenia—Methotrexate—breast cancer	6.87e-06	0.000126	CcSEcCtD
Irinotecan—Chills—Doxorubicin—breast cancer	6.85e-06	0.000125	CcSEcCtD
Irinotecan—Arrhythmia—Doxorubicin—breast cancer	6.82e-06	0.000125	CcSEcCtD
Irinotecan—Dizziness—Paclitaxel—breast cancer	6.78e-06	0.000124	CcSEcCtD
Irinotecan—Alopecia—Doxorubicin—breast cancer	6.75e-06	0.000124	CcSEcCtD
Irinotecan—Cough—Methotrexate—breast cancer	6.7e-06	0.000123	CcSEcCtD
Irinotecan—Ill-defined disorder—Epirubicin—breast cancer	6.66e-06	0.000122	CcSEcCtD
Irinotecan—Body temperature increased—Capecitabine—breast cancer	6.65e-06	0.000122	CcSEcCtD
Irinotecan—Abdominal pain—Capecitabine—breast cancer	6.65e-06	0.000122	CcSEcCtD
Irinotecan—Anaemia—Epirubicin—breast cancer	6.64e-06	0.000122	CcSEcCtD
Irinotecan—Flatulence—Doxorubicin—breast cancer	6.55e-06	0.00012	CcSEcCtD
Irinotecan—Vomiting—Paclitaxel—breast cancer	6.52e-06	0.000119	CcSEcCtD
Irinotecan—Malaise—Epirubicin—breast cancer	6.48e-06	0.000119	CcSEcCtD
Irinotecan—Rash—Paclitaxel—breast cancer	6.46e-06	0.000118	CcSEcCtD
Irinotecan—Dermatitis—Paclitaxel—breast cancer	6.46e-06	0.000118	CcSEcCtD
Irinotecan—Discomfort—Methotrexate—breast cancer	6.46e-06	0.000118	CcSEcCtD
Irinotecan—Vertigo—Epirubicin—breast cancer	6.45e-06	0.000118	CcSEcCtD
Irinotecan—Syncope—Epirubicin—breast cancer	6.44e-06	0.000118	CcSEcCtD
Irinotecan—Leukopenia—Epirubicin—breast cancer	6.43e-06	0.000118	CcSEcCtD
Irinotecan—Back pain—Doxorubicin—breast cancer	6.43e-06	0.000118	CcSEcCtD
Irinotecan—Headache—Paclitaxel—breast cancer	6.42e-06	0.000118	CcSEcCtD
Irinotecan—Hypersensitivity—Docetaxel—breast cancer	6.4e-06	0.000117	CcSEcCtD
Irinotecan—Muscle spasms—Doxorubicin—breast cancer	6.39e-06	0.000117	CcSEcCtD
Irinotecan—Confusional state—Methotrexate—breast cancer	6.32e-06	0.000116	CcSEcCtD
Irinotecan—Loss of consciousness—Epirubicin—breast cancer	6.31e-06	0.000116	CcSEcCtD
Irinotecan—Cough—Epirubicin—breast cancer	6.27e-06	0.000115	CcSEcCtD
Irinotecan—Anaphylactic shock—Methotrexate—breast cancer	6.26e-06	0.000115	CcSEcCtD
Irinotecan—Asthenia—Docetaxel—breast cancer	6.24e-06	0.000114	CcSEcCtD
Irinotecan—Infection—Methotrexate—breast cancer	6.22e-06	0.000114	CcSEcCtD
Irinotecan—Hypertension—Epirubicin—breast cancer	6.2e-06	0.000114	CcSEcCtD
Irinotecan—Hypersensitivity—Capecitabine—breast cancer	6.2e-06	0.000113	CcSEcCtD
Irinotecan—Ill-defined disorder—Doxorubicin—breast cancer	6.17e-06	0.000113	CcSEcCtD
Irinotecan—Nervous system disorder—Methotrexate—breast cancer	6.14e-06	0.000112	CcSEcCtD
Irinotecan—Anaemia—Doxorubicin—breast cancer	6.14e-06	0.000112	CcSEcCtD
Irinotecan—Thrombocytopenia—Methotrexate—breast cancer	6.13e-06	0.000112	CcSEcCtD
Irinotecan—Nausea—Paclitaxel—breast cancer	6.09e-06	0.000111	CcSEcCtD
Irinotecan—Hyperhidrosis—Methotrexate—breast cancer	6.06e-06	0.000111	CcSEcCtD
Irinotecan—Discomfort—Epirubicin—breast cancer	6.04e-06	0.000111	CcSEcCtD
Irinotecan—Asthenia—Capecitabine—breast cancer	6.04e-06	0.000111	CcSEcCtD
Irinotecan—Malaise—Doxorubicin—breast cancer	5.99e-06	0.00011	CcSEcCtD
Irinotecan—Vertigo—Doxorubicin—breast cancer	5.97e-06	0.000109	CcSEcCtD
Irinotecan—Anorexia—Methotrexate—breast cancer	5.97e-06	0.000109	CcSEcCtD
Irinotecan—Syncope—Doxorubicin—breast cancer	5.96e-06	0.000109	CcSEcCtD
Irinotecan—Leukopenia—Doxorubicin—breast cancer	5.95e-06	0.000109	CcSEcCtD
Irinotecan—Diarrhoea—Docetaxel—breast cancer	5.95e-06	0.000109	CcSEcCtD
Irinotecan—Confusional state—Epirubicin—breast cancer	5.91e-06	0.000108	CcSEcCtD
Irinotecan—Anaphylactic shock—Epirubicin—breast cancer	5.86e-06	0.000107	CcSEcCtD
Irinotecan—Oedema—Epirubicin—breast cancer	5.86e-06	0.000107	CcSEcCtD
Irinotecan—Hypotension—Methotrexate—breast cancer	5.85e-06	0.000107	CcSEcCtD
Irinotecan—Loss of consciousness—Doxorubicin—breast cancer	5.84e-06	0.000107	CcSEcCtD
Irinotecan—Infection—Epirubicin—breast cancer	5.82e-06	0.000107	CcSEcCtD
Irinotecan—Cough—Doxorubicin—breast cancer	5.8e-06	0.000106	CcSEcCtD
Irinotecan—Shock—Epirubicin—breast cancer	5.77e-06	0.000106	CcSEcCtD
Irinotecan—Diarrhoea—Capecitabine—breast cancer	5.76e-06	0.000105	CcSEcCtD
Irinotecan—Nervous system disorder—Epirubicin—breast cancer	5.75e-06	0.000105	CcSEcCtD
Irinotecan—Dizziness—Docetaxel—breast cancer	5.75e-06	0.000105	CcSEcCtD
Irinotecan—Thrombocytopenia—Epirubicin—breast cancer	5.74e-06	0.000105	CcSEcCtD
Irinotecan—Hypertension—Doxorubicin—breast cancer	5.74e-06	0.000105	CcSEcCtD
Irinotecan—Hyperhidrosis—Epirubicin—breast cancer	5.67e-06	0.000104	CcSEcCtD
Irinotecan—Insomnia—Methotrexate—breast cancer	5.67e-06	0.000104	CcSEcCtD
Irinotecan—Paraesthesia—Methotrexate—breast cancer	5.62e-06	0.000103	CcSEcCtD
Irinotecan—Discomfort—Doxorubicin—breast cancer	5.59e-06	0.000102	CcSEcCtD
Irinotecan—Anorexia—Epirubicin—breast cancer	5.59e-06	0.000102	CcSEcCtD
Irinotecan—Dyspnoea—Methotrexate—breast cancer	5.58e-06	0.000102	CcSEcCtD
Irinotecan—Somnolence—Methotrexate—breast cancer	5.57e-06	0.000102	CcSEcCtD
Irinotecan—Dizziness—Capecitabine—breast cancer	5.56e-06	0.000102	CcSEcCtD
Irinotecan—Vomiting—Docetaxel—breast cancer	5.53e-06	0.000101	CcSEcCtD
Irinotecan—Dyspepsia—Methotrexate—breast cancer	5.51e-06	0.000101	CcSEcCtD
Irinotecan—Rash—Docetaxel—breast cancer	5.48e-06	0.0001	CcSEcCtD
Irinotecan—Hypotension—Epirubicin—breast cancer	5.48e-06	0.0001	CcSEcCtD
Irinotecan—Dermatitis—Docetaxel—breast cancer	5.47e-06	0.0001	CcSEcCtD
Irinotecan—Confusional state—Doxorubicin—breast cancer	5.47e-06	0.0001	CcSEcCtD
Irinotecan—Decreased appetite—Methotrexate—breast cancer	5.44e-06	9.97e-05	CcSEcCtD
Irinotecan—Headache—Docetaxel—breast cancer	5.44e-06	9.97e-05	CcSEcCtD
Irinotecan—Oedema—Doxorubicin—breast cancer	5.42e-06	9.93e-05	CcSEcCtD
Irinotecan—Anaphylactic shock—Doxorubicin—breast cancer	5.42e-06	9.93e-05	CcSEcCtD
Irinotecan—Gastrointestinal disorder—Methotrexate—breast cancer	5.41e-06	9.9e-05	CcSEcCtD
Irinotecan—Fatigue—Methotrexate—breast cancer	5.4e-06	9.89e-05	CcSEcCtD
Irinotecan—Infection—Doxorubicin—breast cancer	5.39e-06	9.86e-05	CcSEcCtD
Irinotecan—Pain—Methotrexate—breast cancer	5.36e-06	9.81e-05	CcSEcCtD
Irinotecan—Vomiting—Capecitabine—breast cancer	5.35e-06	9.79e-05	CcSEcCtD
Irinotecan—Shock—Doxorubicin—breast cancer	5.34e-06	9.77e-05	CcSEcCtD
Irinotecan—Nervous system disorder—Doxorubicin—breast cancer	5.32e-06	9.74e-05	CcSEcCtD
Irinotecan—Thrombocytopenia—Doxorubicin—breast cancer	5.31e-06	9.72e-05	CcSEcCtD
Irinotecan—Rash—Capecitabine—breast cancer	5.31e-06	9.71e-05	CcSEcCtD
Irinotecan—Insomnia—Epirubicin—breast cancer	5.3e-06	9.71e-05	CcSEcCtD
Irinotecan—Dermatitis—Capecitabine—breast cancer	5.3e-06	9.7e-05	CcSEcCtD
Irinotecan—Headache—Capecitabine—breast cancer	5.27e-06	9.65e-05	CcSEcCtD
Irinotecan—Paraesthesia—Epirubicin—breast cancer	5.26e-06	9.64e-05	CcSEcCtD
Irinotecan—Hyperhidrosis—Doxorubicin—breast cancer	5.24e-06	9.6e-05	CcSEcCtD
Irinotecan—Dyspnoea—Epirubicin—breast cancer	5.23e-06	9.57e-05	CcSEcCtD
Irinotecan—Somnolence—Epirubicin—breast cancer	5.21e-06	9.54e-05	CcSEcCtD
Irinotecan—Anorexia—Doxorubicin—breast cancer	5.17e-06	9.46e-05	CcSEcCtD
Irinotecan—Nausea—Docetaxel—breast cancer	5.16e-06	9.45e-05	CcSEcCtD
Irinotecan—Feeling abnormal—Methotrexate—breast cancer	5.16e-06	9.45e-05	CcSEcCtD
Irinotecan—Dyspepsia—Epirubicin—breast cancer	5.16e-06	9.45e-05	CcSEcCtD
Irinotecan—Gastrointestinal pain—Methotrexate—breast cancer	5.12e-06	9.38e-05	CcSEcCtD
Irinotecan—Decreased appetite—Epirubicin—breast cancer	5.1e-06	9.33e-05	CcSEcCtD
Irinotecan—Hypotension—Doxorubicin—breast cancer	5.07e-06	9.28e-05	CcSEcCtD
Irinotecan—Gastrointestinal disorder—Epirubicin—breast cancer	5.06e-06	9.26e-05	CcSEcCtD
Irinotecan—Fatigue—Epirubicin—breast cancer	5.05e-06	9.25e-05	CcSEcCtD
Irinotecan—Pain—Epirubicin—breast cancer	5.01e-06	9.18e-05	CcSEcCtD
Irinotecan—Constipation—Epirubicin—breast cancer	5.01e-06	9.18e-05	CcSEcCtD
Irinotecan—Nausea—Capecitabine—breast cancer	5e-06	9.15e-05	CcSEcCtD
Irinotecan—Abdominal pain—Methotrexate—breast cancer	4.95e-06	9.06e-05	CcSEcCtD
Irinotecan—Body temperature increased—Methotrexate—breast cancer	4.95e-06	9.06e-05	CcSEcCtD
Irinotecan—Insomnia—Doxorubicin—breast cancer	4.91e-06	8.98e-05	CcSEcCtD
Irinotecan—Paraesthesia—Doxorubicin—breast cancer	4.87e-06	8.92e-05	CcSEcCtD
Irinotecan—Dyspnoea—Doxorubicin—breast cancer	4.84e-06	8.85e-05	CcSEcCtD
Irinotecan—Feeling abnormal—Epirubicin—breast cancer	4.83e-06	8.84e-05	CcSEcCtD
Irinotecan—Somnolence—Doxorubicin—breast cancer	4.82e-06	8.83e-05	CcSEcCtD
Irinotecan—Gastrointestinal pain—Epirubicin—breast cancer	4.79e-06	8.78e-05	CcSEcCtD
Irinotecan—Dyspepsia—Doxorubicin—breast cancer	4.77e-06	8.74e-05	CcSEcCtD
Irinotecan—Decreased appetite—Doxorubicin—breast cancer	4.71e-06	8.63e-05	CcSEcCtD
Irinotecan—Gastrointestinal disorder—Doxorubicin—breast cancer	4.68e-06	8.57e-05	CcSEcCtD
Irinotecan—Fatigue—Doxorubicin—breast cancer	4.68e-06	8.56e-05	CcSEcCtD
Irinotecan—Pain—Doxorubicin—breast cancer	4.64e-06	8.49e-05	CcSEcCtD
Irinotecan—Constipation—Doxorubicin—breast cancer	4.64e-06	8.49e-05	CcSEcCtD
Irinotecan—Abdominal pain—Epirubicin—breast cancer	4.63e-06	8.48e-05	CcSEcCtD
Irinotecan—Body temperature increased—Epirubicin—breast cancer	4.63e-06	8.48e-05	CcSEcCtD
Irinotecan—Hypersensitivity—Methotrexate—breast cancer	4.61e-06	8.45e-05	CcSEcCtD
Irinotecan—Asthenia—Methotrexate—breast cancer	4.49e-06	8.23e-05	CcSEcCtD
Irinotecan—Feeling abnormal—Doxorubicin—breast cancer	4.47e-06	8.18e-05	CcSEcCtD
Irinotecan—Gastrointestinal pain—Doxorubicin—breast cancer	4.43e-06	8.12e-05	CcSEcCtD
Irinotecan—Hypersensitivity—Epirubicin—breast cancer	4.32e-06	7.91e-05	CcSEcCtD
Irinotecan—Body temperature increased—Doxorubicin—breast cancer	4.29e-06	7.85e-05	CcSEcCtD
Irinotecan—Abdominal pain—Doxorubicin—breast cancer	4.29e-06	7.85e-05	CcSEcCtD
Irinotecan—Diarrhoea—Methotrexate—breast cancer	4.29e-06	7.85e-05	CcSEcCtD
Irinotecan—Asthenia—Epirubicin—breast cancer	4.21e-06	7.7e-05	CcSEcCtD
Irinotecan—Dizziness—Methotrexate—breast cancer	4.14e-06	7.58e-05	CcSEcCtD
Irinotecan—Diarrhoea—Epirubicin—breast cancer	4.01e-06	7.34e-05	CcSEcCtD
Irinotecan—Hypersensitivity—Doxorubicin—breast cancer	4e-06	7.32e-05	CcSEcCtD
Irinotecan—Vomiting—Methotrexate—breast cancer	3.98e-06	7.29e-05	CcSEcCtD
Irinotecan—Rash—Methotrexate—breast cancer	3.95e-06	7.23e-05	CcSEcCtD
Irinotecan—Dermatitis—Methotrexate—breast cancer	3.95e-06	7.22e-05	CcSEcCtD
Irinotecan—Headache—Methotrexate—breast cancer	3.92e-06	7.18e-05	CcSEcCtD
Irinotecan—Asthenia—Doxorubicin—breast cancer	3.89e-06	7.12e-05	CcSEcCtD
Irinotecan—Dizziness—Epirubicin—breast cancer	3.88e-06	7.1e-05	CcSEcCtD
Irinotecan—Vomiting—Epirubicin—breast cancer	3.73e-06	6.82e-05	CcSEcCtD
Irinotecan—Nausea—Methotrexate—breast cancer	3.72e-06	6.81e-05	CcSEcCtD
Irinotecan—Diarrhoea—Doxorubicin—breast cancer	3.71e-06	6.79e-05	CcSEcCtD
Irinotecan—Rash—Epirubicin—breast cancer	3.7e-06	6.77e-05	CcSEcCtD
Irinotecan—Dermatitis—Epirubicin—breast cancer	3.69e-06	6.76e-05	CcSEcCtD
Irinotecan—Headache—Epirubicin—breast cancer	3.67e-06	6.72e-05	CcSEcCtD
Irinotecan—Dizziness—Doxorubicin—breast cancer	3.59e-06	6.57e-05	CcSEcCtD
Irinotecan—Nausea—Epirubicin—breast cancer	3.48e-06	6.37e-05	CcSEcCtD
Irinotecan—Vomiting—Doxorubicin—breast cancer	3.45e-06	6.31e-05	CcSEcCtD
Irinotecan—Rash—Doxorubicin—breast cancer	3.42e-06	6.26e-05	CcSEcCtD
Irinotecan—Dermatitis—Doxorubicin—breast cancer	3.42e-06	6.25e-05	CcSEcCtD
Irinotecan—Headache—Doxorubicin—breast cancer	3.4e-06	6.22e-05	CcSEcCtD
Irinotecan—Nausea—Doxorubicin—breast cancer	3.22e-06	5.9e-05	CcSEcCtD
Irinotecan—ABCB1—Metabolism—NCOA2—breast cancer	6.03e-07	1.74e-05	CbGpPWpGaD
Irinotecan—ACHE—Metabolism—NOS3—breast cancer	6.03e-07	1.74e-05	CbGpPWpGaD
Irinotecan—ABCC1—Disease—PTGS2—breast cancer	6.03e-07	1.74e-05	CbGpPWpGaD
Irinotecan—UGT1A1—Metabolism—ALB—breast cancer	5.98e-07	1.73e-05	CbGpPWpGaD
Irinotecan—UGT1A9—Metabolism—ALB—breast cancer	5.98e-07	1.73e-05	CbGpPWpGaD
Irinotecan—ALB—Metabolism—HSP90AA1—breast cancer	5.96e-07	1.72e-05	CbGpPWpGaD
Irinotecan—CYP2B6—Metabolism—ABCB1—breast cancer	5.95e-07	1.72e-05	CbGpPWpGaD
Irinotecan—ABCB1—Transmembrane transport of small molecules—ALB—breast cancer	5.86e-07	1.69e-05	CbGpPWpGaD
Irinotecan—ABCG2—Metabolism—PIK3CG—breast cancer	5.85e-07	1.69e-05	CbGpPWpGaD
Irinotecan—ABCB1—Metabolism—FASN—breast cancer	5.85e-07	1.69e-05	CbGpPWpGaD
Irinotecan—ABCC1—Metabolism—PIK3CD—breast cancer	5.84e-07	1.69e-05	CbGpPWpGaD
Irinotecan—CYP2B6—Metabolism—TYMS—breast cancer	5.84e-07	1.69e-05	CbGpPWpGaD
Irinotecan—ABCB1—Metabolism—BCHE—breast cancer	5.82e-07	1.68e-05	CbGpPWpGaD
Irinotecan—CYP3A5—Metabolism—ABCB1—breast cancer	5.81e-07	1.68e-05	CbGpPWpGaD
Irinotecan—ALB—Metabolism—NCOA1—breast cancer	5.8e-07	1.67e-05	CbGpPWpGaD
Irinotecan—CYP3A7—Metabolism—PIK3CG—breast cancer	5.8e-07	1.67e-05	CbGpPWpGaD
Irinotecan—CYP2B6—Metabolism—NCOR1—breast cancer	5.77e-07	1.67e-05	CbGpPWpGaD
Irinotecan—CYP2B6—Metabolism—GSTM1—breast cancer	5.77e-07	1.67e-05	CbGpPWpGaD
Irinotecan—CYP2B6—Metabolism—PLA2G4A—breast cancer	5.77e-07	1.67e-05	CbGpPWpGaD
Irinotecan—ABCC1—Metabolism—ALB—breast cancer	5.77e-07	1.66e-05	CbGpPWpGaD
Irinotecan—ABCB1—Metabolism—SLC5A5—breast cancer	5.75e-07	1.66e-05	CbGpPWpGaD
Irinotecan—UGT1A1—Metabolism—NOS3—breast cancer	5.72e-07	1.65e-05	CbGpPWpGaD
Irinotecan—UGT1A9—Metabolism—NOS3—breast cancer	5.72e-07	1.65e-05	CbGpPWpGaD
Irinotecan—ALB—Metabolism—STK11—breast cancer	5.72e-07	1.65e-05	CbGpPWpGaD
Irinotecan—ALB—Metabolism—CYP19A1—breast cancer	5.72e-07	1.65e-05	CbGpPWpGaD
Irinotecan—CYP3A4—Metabolism—GSTA4—breast cancer	5.71e-07	1.65e-05	CbGpPWpGaD
Irinotecan—CYP3A4—Metabolism—CA9—breast cancer	5.71e-07	1.65e-05	CbGpPWpGaD
Irinotecan—CYP3A5—Metabolism—TYMS—breast cancer	5.71e-07	1.65e-05	CbGpPWpGaD
Irinotecan—ABCC1—Disease—CDKN1B—breast cancer	5.71e-07	1.65e-05	CbGpPWpGaD
Irinotecan—BCHE—Metabolism—PIK3CD—breast cancer	5.7e-07	1.64e-05	CbGpPWpGaD
Irinotecan—CYP3A5—Metabolism—PLA2G4A—breast cancer	5.64e-07	1.63e-05	CbGpPWpGaD
Irinotecan—CYP3A5—Metabolism—NCOR1—breast cancer	5.64e-07	1.63e-05	CbGpPWpGaD
Irinotecan—CYP3A5—Metabolism—GSTM1—breast cancer	5.64e-07	1.63e-05	CbGpPWpGaD
Irinotecan—BCHE—Metabolism—ALB—breast cancer	5.62e-07	1.62e-05	CbGpPWpGaD
Irinotecan—CYP3A4—Metabolism—GPX2—breast cancer	5.57e-07	1.61e-05	CbGpPWpGaD
Irinotecan—CYP3A4—Metabolism—GSTA2—breast cancer	5.57e-07	1.61e-05	CbGpPWpGaD
Irinotecan—ACHE—Metabolism—PIK3CB—breast cancer	5.57e-07	1.61e-05	CbGpPWpGaD
Irinotecan—ABCB1—Metabolism—SLC2A1—breast cancer	5.56e-07	1.6e-05	CbGpPWpGaD
Irinotecan—ABCB1—Metabolism—NQO1—breast cancer	5.56e-07	1.6e-05	CbGpPWpGaD
Irinotecan—SLCO1B1—Metabolism—PIK3CD—breast cancer	5.55e-07	1.6e-05	CbGpPWpGaD
Irinotecan—CYP2B6—Metabolism—GPX1—breast cancer	5.53e-07	1.6e-05	CbGpPWpGaD
Irinotecan—ABCC1—Metabolism—NOS3—breast cancer	5.52e-07	1.59e-05	CbGpPWpGaD
Irinotecan—ACHE—Metabolism—PTGS2—breast cancer	5.51e-07	1.59e-05	CbGpPWpGaD
Irinotecan—CYP3A4—Metabolism—GPX4—breast cancer	5.5e-07	1.59e-05	CbGpPWpGaD
Irinotecan—CYP3A4—Metabolism—SULT1A1—breast cancer	5.5e-07	1.59e-05	CbGpPWpGaD
Irinotecan—SLCO1B1—Metabolism—ALB—breast cancer	5.48e-07	1.58e-05	CbGpPWpGaD
Irinotecan—CYP2B6—Metabolism—CYP1A1—breast cancer	5.47e-07	1.58e-05	CbGpPWpGaD
Irinotecan—ALB—Hemostasis—SRC—breast cancer	5.47e-07	1.58e-05	CbGpPWpGaD
Irinotecan—CYP2B6—Metabolism—ERCC2—breast cancer	5.43e-07	1.57e-05	CbGpPWpGaD
Irinotecan—ABCB1—Metabolism—CYP3A4—breast cancer	5.42e-07	1.56e-05	CbGpPWpGaD
Irinotecan—CYP3A5—Metabolism—GPX1—breast cancer	5.4e-07	1.56e-05	CbGpPWpGaD
Irinotecan—ABCC1—Disease—CTNNB1—breast cancer	5.39e-07	1.56e-05	CbGpPWpGaD
Irinotecan—BCHE—Metabolism—NOS3—breast cancer	5.38e-07	1.55e-05	CbGpPWpGaD
Irinotecan—CYP3A4—Metabolism—GSTA1—breast cancer	5.37e-07	1.55e-05	CbGpPWpGaD
Irinotecan—CYP3A4—Metabolism—IDH1—breast cancer	5.37e-07	1.55e-05	CbGpPWpGaD
Irinotecan—ALB—Metabolism of lipids and lipoproteins—PTEN—breast cancer	5.37e-07	1.55e-05	CbGpPWpGaD
Irinotecan—CYP3A5—Metabolism—CYP1A1—breast cancer	5.35e-07	1.54e-05	CbGpPWpGaD
Irinotecan—ABCB1—Metabolism—CYP1B1—breast cancer	5.33e-07	1.54e-05	CbGpPWpGaD
Irinotecan—ALB—Hemostasis—VEGFA—breast cancer	5.32e-07	1.54e-05	CbGpPWpGaD
Irinotecan—ALB—Metabolism—COMT—breast cancer	5.31e-07	1.53e-05	CbGpPWpGaD
Irinotecan—CYP3A4—Metabolism—NAT2—breast cancer	5.31e-07	1.53e-05	CbGpPWpGaD
Irinotecan—CYP3A5—Metabolism—ERCC2—breast cancer	5.31e-07	1.53e-05	CbGpPWpGaD
Irinotecan—ABCB1—Transmembrane transport of small molecules—RAF1—breast cancer	5.3e-07	1.53e-05	CbGpPWpGaD
Irinotecan—ALB—Metabolism—GSTP1—breast cancer	5.29e-07	1.53e-05	CbGpPWpGaD
Irinotecan—UGT1A1—Metabolism—PIK3CB—breast cancer	5.28e-07	1.52e-05	CbGpPWpGaD
Irinotecan—UGT1A9—Metabolism—PIK3CB—breast cancer	5.28e-07	1.52e-05	CbGpPWpGaD
Irinotecan—ABCC1—Disease—CDKN1A—breast cancer	5.27e-07	1.52e-05	CbGpPWpGaD
Irinotecan—ABCC1—Disease—PTEN—breast cancer	5.25e-07	1.52e-05	CbGpPWpGaD
Irinotecan—SLCO1B1—Metabolism—NOS3—breast cancer	5.24e-07	1.51e-05	CbGpPWpGaD
Irinotecan—UGT1A1—Metabolism—PTGS2—breast cancer	5.23e-07	1.51e-05	CbGpPWpGaD
Irinotecan—UGT1A9—Metabolism—PTGS2—breast cancer	5.23e-07	1.51e-05	CbGpPWpGaD
Irinotecan—ABCB1—Metabolism—HSP90AA1—breast cancer	5.22e-07	1.51e-05	CbGpPWpGaD
Irinotecan—ALB—Metabolism—HMOX1—breast cancer	5.22e-07	1.5e-05	CbGpPWpGaD
Irinotecan—ALB—Metabolism—ITPR1—breast cancer	5.2e-07	1.5e-05	CbGpPWpGaD
Irinotecan—ABCG2—Metabolism—PIK3CD—breast cancer	5.14e-07	1.48e-05	CbGpPWpGaD
Irinotecan—CYP2B6—Metabolism—MTHFR—breast cancer	5.1e-07	1.47e-05	CbGpPWpGaD
Irinotecan—CYP3A7—Metabolism—PIK3CD—breast cancer	5.1e-07	1.47e-05	CbGpPWpGaD
Irinotecan—ABCC1—Metabolism—PIK3CB—breast cancer	5.09e-07	1.47e-05	CbGpPWpGaD
Irinotecan—ABCB1—Metabolism—NCOA1—breast cancer	5.08e-07	1.47e-05	CbGpPWpGaD
Irinotecan—ABCG2—Metabolism—ALB—breast cancer	5.08e-07	1.46e-05	CbGpPWpGaD
Irinotecan—ABCC1—Metabolism—PTGS2—breast cancer	5.05e-07	1.46e-05	CbGpPWpGaD
Irinotecan—ALB—Hemostasis—MAPK3—breast cancer	5.04e-07	1.45e-05	CbGpPWpGaD
Irinotecan—CYP3A7—Metabolism—ALB—breast cancer	5.03e-07	1.45e-05	CbGpPWpGaD
Irinotecan—ABCB1—Metabolism—CYP19A1—breast cancer	5.01e-07	1.44e-05	CbGpPWpGaD
Irinotecan—ABCB1—Metabolism—STK11—breast cancer	5.01e-07	1.44e-05	CbGpPWpGaD
Irinotecan—ALB—Metabolism—ABCB1—breast cancer	5.01e-07	1.44e-05	CbGpPWpGaD
Irinotecan—CYP3A5—Metabolism—MTHFR—breast cancer	4.99e-07	1.44e-05	CbGpPWpGaD
Irinotecan—BCHE—Metabolism—PIK3CB—breast cancer	4.97e-07	1.43e-05	CbGpPWpGaD
Irinotecan—BCHE—Metabolism—PTGS2—breast cancer	4.92e-07	1.42e-05	CbGpPWpGaD
Irinotecan—ALB—Metabolism—TYMS—breast cancer	4.92e-07	1.42e-05	CbGpPWpGaD
Irinotecan—ALB—Hemostasis—TGFB1—breast cancer	4.89e-07	1.41e-05	CbGpPWpGaD
Irinotecan—ABCC1—Disease—SRC—breast cancer	4.87e-07	1.41e-05	CbGpPWpGaD
Irinotecan—ALB—Metabolism—NCOR1—breast cancer	4.86e-07	1.4e-05	CbGpPWpGaD
Irinotecan—ALB—Metabolism—PLA2G4A—breast cancer	4.86e-07	1.4e-05	CbGpPWpGaD
Irinotecan—ALB—Metabolism—GSTM1—breast cancer	4.86e-07	1.4e-05	CbGpPWpGaD
Irinotecan—ABCG2—Metabolism—NOS3—breast cancer	4.85e-07	1.4e-05	CbGpPWpGaD
Irinotecan—SLCO1B1—Metabolism—PIK3CB—breast cancer	4.84e-07	1.4e-05	CbGpPWpGaD
Irinotecan—CYP3A7—Metabolism—NOS3—breast cancer	4.81e-07	1.39e-05	CbGpPWpGaD
Irinotecan—ACHE—Metabolism—PTEN—breast cancer	4.81e-07	1.39e-05	CbGpPWpGaD
Irinotecan—SLCO1B1—Metabolism—PTGS2—breast cancer	4.8e-07	1.38e-05	CbGpPWpGaD
Irinotecan—CYP2B6—Metabolism—CAV1—breast cancer	4.71e-07	1.36e-05	CbGpPWpGaD
Irinotecan—ABCC1—Disease—STAT3—breast cancer	4.7e-07	1.36e-05	CbGpPWpGaD
Irinotecan—CYP3A4—Metabolism—MED12—breast cancer	4.66e-07	1.34e-05	CbGpPWpGaD
Irinotecan—CYP3A4—Metabolism—DPYD—breast cancer	4.66e-07	1.34e-05	CbGpPWpGaD
Irinotecan—ABCB1—Metabolism—COMT—breast cancer	4.66e-07	1.34e-05	CbGpPWpGaD
Irinotecan—ALB—Metabolism—GPX1—breast cancer	4.65e-07	1.34e-05	CbGpPWpGaD
Irinotecan—ABCB1—Metabolism—GSTP1—breast cancer	4.63e-07	1.34e-05	CbGpPWpGaD
Irinotecan—ALB—Metabolism—CYP1A1—breast cancer	4.61e-07	1.33e-05	CbGpPWpGaD
Irinotecan—CYP3A5—Metabolism—CAV1—breast cancer	4.6e-07	1.33e-05	CbGpPWpGaD
Irinotecan—CYP3A4—Metabolism—ALDOA—breast cancer	4.59e-07	1.32e-05	CbGpPWpGaD
Irinotecan—ABCB1—Metabolism—HMOX1—breast cancer	4.57e-07	1.32e-05	CbGpPWpGaD
Irinotecan—ALB—Metabolism—ERCC2—breast cancer	4.57e-07	1.32e-05	CbGpPWpGaD
Irinotecan—UGT1A1—Metabolism—PTEN—breast cancer	4.56e-07	1.32e-05	CbGpPWpGaD
Irinotecan—UGT1A9—Metabolism—PTEN—breast cancer	4.56e-07	1.32e-05	CbGpPWpGaD
Irinotecan—ABCB1—Metabolism—ITPR1—breast cancer	4.56e-07	1.32e-05	CbGpPWpGaD
Irinotecan—ALB—Hemostasis—KRAS—breast cancer	4.53e-07	1.31e-05	CbGpPWpGaD
Irinotecan—ABCC1—Disease—MAPK3—breast cancer	4.49e-07	1.3e-05	CbGpPWpGaD
Irinotecan—ABCG2—Metabolism—PIK3CB—breast cancer	4.48e-07	1.29e-05	CbGpPWpGaD
Irinotecan—CYP3A4—Metabolism—NCOA3—breast cancer	4.45e-07	1.28e-05	CbGpPWpGaD
Irinotecan—CYP3A7—Metabolism—PIK3CB—breast cancer	4.44e-07	1.28e-05	CbGpPWpGaD
Irinotecan—ABCG2—Metabolism—PTGS2—breast cancer	4.44e-07	1.28e-05	CbGpPWpGaD
Irinotecan—CYP3A4—Metabolism—SLC2A2—breast cancer	4.42e-07	1.28e-05	CbGpPWpGaD
Irinotecan—CYP3A7—Metabolism—PTGS2—breast cancer	4.4e-07	1.27e-05	CbGpPWpGaD
Irinotecan—ABCC1—Metabolism—PTEN—breast cancer	4.4e-07	1.27e-05	CbGpPWpGaD
Irinotecan—ABCC1—Disease—MYC—breast cancer	4.37e-07	1.26e-05	CbGpPWpGaD
Irinotecan—ABCC1—Disease—TGFB1—breast cancer	4.36e-07	1.26e-05	CbGpPWpGaD
Irinotecan—CYP3A4—Metabolism—CPT1A—breast cancer	4.33e-07	1.25e-05	CbGpPWpGaD
Irinotecan—CYP3A4—Metabolism—MTR—breast cancer	4.33e-07	1.25e-05	CbGpPWpGaD
Irinotecan—CYP3A4—Metabolism—ABCG2—breast cancer	4.33e-07	1.25e-05	CbGpPWpGaD
Irinotecan—SLC22A3—Metabolism—PIK3CA—breast cancer	4.31e-07	1.24e-05	CbGpPWpGaD
Irinotecan—ABCB1—Metabolism—TYMS—breast cancer	4.31e-07	1.24e-05	CbGpPWpGaD
Irinotecan—ALB—Metabolism—MTHFR—breast cancer	4.29e-07	1.24e-05	CbGpPWpGaD
Irinotecan—BCHE—Metabolism—PTEN—breast cancer	4.29e-07	1.24e-05	CbGpPWpGaD
Irinotecan—CYP2B6—Metabolism—PIK3CG—breast cancer	4.29e-07	1.24e-05	CbGpPWpGaD
Irinotecan—ABCC1—Disease—EGFR—breast cancer	4.27e-07	1.23e-05	CbGpPWpGaD
Irinotecan—ABCB1—Metabolism—NCOR1—breast cancer	4.26e-07	1.23e-05	CbGpPWpGaD
Irinotecan—ABCB1—Metabolism—PLA2G4A—breast cancer	4.26e-07	1.23e-05	CbGpPWpGaD
Irinotecan—ABCB1—Metabolism—GSTM1—breast cancer	4.26e-07	1.23e-05	CbGpPWpGaD
Irinotecan—CYP3A4—Metabolism—HPGDS—breast cancer	4.25e-07	1.23e-05	CbGpPWpGaD
Irinotecan—CYP3A4—Metabolism—HBA1—breast cancer	4.22e-07	1.22e-05	CbGpPWpGaD
Irinotecan—CYP3A5—Metabolism—PIK3CG—breast cancer	4.19e-07	1.21e-05	CbGpPWpGaD
Irinotecan—SLCO1B1—Metabolism—PTEN—breast cancer	4.18e-07	1.21e-05	CbGpPWpGaD
Irinotecan—ALB—Hemostasis—PIK3CA—breast cancer	4.16e-07	1.2e-05	CbGpPWpGaD
Irinotecan—CYP3A4—Metabolism—GSTT1—breast cancer	4.12e-07	1.19e-05	CbGpPWpGaD
Irinotecan—CYP3A4—Metabolism—ACHE—breast cancer	4.12e-07	1.19e-05	CbGpPWpGaD
Irinotecan—ABCB1—Metabolism—GPX1—breast cancer	4.08e-07	1.18e-05	CbGpPWpGaD
Irinotecan—ABCB1—Metabolism—CYP1A1—breast cancer	4.04e-07	1.16e-05	CbGpPWpGaD
Irinotecan—ABCC1—Disease—KRAS—breast cancer	4.03e-07	1.16e-05	CbGpPWpGaD
Irinotecan—ALB—Hemostasis—TP53—breast cancer	4.02e-07	1.16e-05	CbGpPWpGaD
Irinotecan—ABCB1—Metabolism—ERCC2—breast cancer	4e-07	1.16e-05	CbGpPWpGaD
Irinotecan—ALB—Metabolism—CAV1—breast cancer	3.96e-07	1.14e-05	CbGpPWpGaD
Irinotecan—CYP3A4—Metabolism—CYP17A1—breast cancer	3.9e-07	1.12e-05	CbGpPWpGaD
Irinotecan—ABCG2—Metabolism—PTEN—breast cancer	3.87e-07	1.12e-05	CbGpPWpGaD
Irinotecan—CYP3A4—Metabolism—ENO1—breast cancer	3.86e-07	1.11e-05	CbGpPWpGaD
Irinotecan—CYP3A4—Metabolism—PTGS1—breast cancer	3.86e-07	1.11e-05	CbGpPWpGaD
Irinotecan—ALB—Hemostasis—HRAS—breast cancer	3.85e-07	1.11e-05	CbGpPWpGaD
Irinotecan—CYP3A7—Metabolism—PTEN—breast cancer	3.84e-07	1.11e-05	CbGpPWpGaD
Irinotecan—ALB—Metabolism of lipids and lipoproteins—PIK3CA—breast cancer	3.78e-07	1.09e-05	CbGpPWpGaD
Irinotecan—CYP3A4—Metabolism—CYP2D6—breast cancer	3.78e-07	1.09e-05	CbGpPWpGaD
Irinotecan—CYP2B6—Metabolism—PIK3CD—breast cancer	3.77e-07	1.09e-05	CbGpPWpGaD
Irinotecan—ABCB1—Metabolism—MTHFR—breast cancer	3.76e-07	1.09e-05	CbGpPWpGaD
Irinotecan—CYP2B6—Metabolism—ALB—breast cancer	3.72e-07	1.07e-05	CbGpPWpGaD
Irinotecan—CYP3A4—Metabolism—NCOA2—breast cancer	3.71e-07	1.07e-05	CbGpPWpGaD
Irinotecan—ABCC1—Disease—PIK3CA—breast cancer	3.71e-07	1.07e-05	CbGpPWpGaD
Irinotecan—CYP3A5—Metabolism—PIK3CD—breast cancer	3.68e-07	1.06e-05	CbGpPWpGaD
Irinotecan—CYP3A5—Metabolism—ALB—breast cancer	3.64e-07	1.05e-05	CbGpPWpGaD
Irinotecan—ALB—Metabolism—PIK3CG—breast cancer	3.61e-07	1.04e-05	CbGpPWpGaD
Irinotecan—CYP3A4—Metabolism—FASN—breast cancer	3.6e-07	1.04e-05	CbGpPWpGaD
Irinotecan—CYP3A4—Metabolism—BCHE—breast cancer	3.59e-07	1.04e-05	CbGpPWpGaD
Irinotecan—CYP2B6—Metabolism—NOS3—breast cancer	3.56e-07	1.03e-05	CbGpPWpGaD
Irinotecan—CYP3A4—Metabolism—SLC5A5—breast cancer	3.54e-07	1.02e-05	CbGpPWpGaD
Irinotecan—SLC22A3—Metabolism—AKT1—breast cancer	3.52e-07	1.02e-05	CbGpPWpGaD
Irinotecan—CYP3A5—Metabolism—NOS3—breast cancer	3.48e-07	1e-05	CbGpPWpGaD
Irinotecan—ABCB1—Metabolism—CAV1—breast cancer	3.47e-07	1e-05	CbGpPWpGaD
Irinotecan—ABCC1—Disease—HRAS—breast cancer	3.43e-07	9.89e-06	CbGpPWpGaD
Irinotecan—CYP3A4—Metabolism—SLC2A1—breast cancer	3.42e-07	9.88e-06	CbGpPWpGaD
Irinotecan—CYP3A4—Metabolism—NQO1—breast cancer	3.42e-07	9.88e-06	CbGpPWpGaD
Irinotecan—ALB—Hemostasis—AKT1—breast cancer	3.4e-07	9.8e-06	CbGpPWpGaD
Irinotecan—ACHE—Metabolism—PIK3CA—breast cancer	3.39e-07	9.79e-06	CbGpPWpGaD
Irinotecan—CYP2B6—Metabolism—PIK3CB—breast cancer	3.28e-07	9.48e-06	CbGpPWpGaD
Irinotecan—ABCC1—Disease—IL6—breast cancer	3.28e-07	9.47e-06	CbGpPWpGaD
Irinotecan—CYP3A4—Metabolism—CYP1B1—breast cancer	3.28e-07	9.47e-06	CbGpPWpGaD
Irinotecan—CYP2B6—Metabolism—PTGS2—breast cancer	3.25e-07	9.39e-06	CbGpPWpGaD
Irinotecan—UGT1A1—Metabolism—PIK3CA—breast cancer	3.22e-07	9.29e-06	CbGpPWpGaD
Irinotecan—UGT1A9—Metabolism—PIK3CA—breast cancer	3.22e-07	9.29e-06	CbGpPWpGaD
Irinotecan—CYP3A4—Metabolism—HSP90AA1—breast cancer	3.22e-07	9.28e-06	CbGpPWpGaD
Irinotecan—CYP3A5—Metabolism—PIK3CB—breast cancer	3.21e-07	9.26e-06	CbGpPWpGaD
Irinotecan—CYP3A5—Metabolism—PTGS2—breast cancer	3.18e-07	9.18e-06	CbGpPWpGaD
Irinotecan—ALB—Metabolism—PIK3CD—breast cancer	3.17e-07	9.15e-06	CbGpPWpGaD
Irinotecan—ABCB1—Metabolism—PIK3CG—breast cancer	3.16e-07	9.12e-06	CbGpPWpGaD
Irinotecan—CYP3A4—Metabolism—NCOA1—breast cancer	3.13e-07	9.03e-06	CbGpPWpGaD
Irinotecan—ABCC1—Metabolism—PIK3CA—breast cancer	3.1e-07	8.96e-06	CbGpPWpGaD
Irinotecan—CYP3A4—Metabolism—CYP19A1—breast cancer	3.09e-07	8.9e-06	CbGpPWpGaD
Irinotecan—CYP3A4—Metabolism—STK11—breast cancer	3.09e-07	8.9e-06	CbGpPWpGaD
Irinotecan—ABCC1—Disease—AKT1—breast cancer	3.03e-07	8.74e-06	CbGpPWpGaD
Irinotecan—BCHE—Metabolism—PIK3CA—breast cancer	3.03e-07	8.73e-06	CbGpPWpGaD
Irinotecan—ALB—Metabolism—NOS3—breast cancer	3e-07	8.64e-06	CbGpPWpGaD
Irinotecan—SLCO1B1—Metabolism—PIK3CA—breast cancer	2.95e-07	8.51e-06	CbGpPWpGaD
Irinotecan—CYP3A4—Metabolism—COMT—breast cancer	2.87e-07	8.28e-06	CbGpPWpGaD
Irinotecan—CYP3A4—Metabolism—GSTP1—breast cancer	2.85e-07	8.24e-06	CbGpPWpGaD
Irinotecan—CYP2B6—Metabolism—PTEN—breast cancer	2.84e-07	8.19e-06	CbGpPWpGaD
Irinotecan—CYP3A4—Metabolism—HMOX1—breast cancer	2.82e-07	8.12e-06	CbGpPWpGaD
Irinotecan—CYP3A4—Metabolism—ITPR1—breast cancer	2.81e-07	8.1e-06	CbGpPWpGaD
Irinotecan—ABCB1—Metabolism—PIK3CD—breast cancer	2.78e-07	8.02e-06	CbGpPWpGaD
Irinotecan—CYP3A5—Metabolism—PTEN—breast cancer	2.77e-07	8e-06	CbGpPWpGaD
Irinotecan—ACHE—Metabolism—AKT1—breast cancer	2.77e-07	8e-06	CbGpPWpGaD
Irinotecan—ALB—Metabolism—PIK3CB—breast cancer	2.77e-07	7.98e-06	CbGpPWpGaD
Irinotecan—ABCB1—Metabolism—ALB—breast cancer	2.74e-07	7.92e-06	CbGpPWpGaD
Irinotecan—ALB—Metabolism—PTGS2—breast cancer	2.74e-07	7.9e-06	CbGpPWpGaD
Irinotecan—ABCG2—Metabolism—PIK3CA—breast cancer	2.73e-07	7.88e-06	CbGpPWpGaD
Irinotecan—CYP3A7—Metabolism—PIK3CA—breast cancer	2.71e-07	7.81e-06	CbGpPWpGaD
Irinotecan—CYP3A4—Metabolism—ABCB1—breast cancer	2.7e-07	7.8e-06	CbGpPWpGaD
Irinotecan—CYP3A4—Metabolism—TYMS—breast cancer	2.65e-07	7.66e-06	CbGpPWpGaD
Irinotecan—UGT1A1—Metabolism—AKT1—breast cancer	2.63e-07	7.59e-06	CbGpPWpGaD
Irinotecan—UGT1A9—Metabolism—AKT1—breast cancer	2.63e-07	7.59e-06	CbGpPWpGaD
Irinotecan—ABCB1—Metabolism—NOS3—breast cancer	2.62e-07	7.57e-06	CbGpPWpGaD
Irinotecan—CYP3A4—Metabolism—NCOR1—breast cancer	2.62e-07	7.57e-06	CbGpPWpGaD
Irinotecan—CYP3A4—Metabolism—GSTM1—breast cancer	2.62e-07	7.57e-06	CbGpPWpGaD
Irinotecan—CYP3A4—Metabolism—PLA2G4A—breast cancer	2.62e-07	7.57e-06	CbGpPWpGaD
Irinotecan—ABCC1—Metabolism—AKT1—breast cancer	2.54e-07	7.32e-06	CbGpPWpGaD
Irinotecan—CYP3A4—Metabolism—GPX1—breast cancer	2.51e-07	7.25e-06	CbGpPWpGaD
Irinotecan—CYP3A4—Metabolism—CYP1A1—breast cancer	2.49e-07	7.18e-06	CbGpPWpGaD
Irinotecan—BCHE—Metabolism—AKT1—breast cancer	2.47e-07	7.13e-06	CbGpPWpGaD
Irinotecan—CYP3A4—Metabolism—ERCC2—breast cancer	2.47e-07	7.12e-06	CbGpPWpGaD
Irinotecan—ABCB1—Metabolism—PIK3CB—breast cancer	2.42e-07	6.99e-06	CbGpPWpGaD
Irinotecan—SLCO1B1—Metabolism—AKT1—breast cancer	2.41e-07	6.95e-06	CbGpPWpGaD
Irinotecan—ABCB1—Metabolism—PTGS2—breast cancer	2.4e-07	6.93e-06	CbGpPWpGaD
Irinotecan—ALB—Metabolism—PTEN—breast cancer	2.39e-07	6.89e-06	CbGpPWpGaD
Irinotecan—CYP3A4—Metabolism—MTHFR—breast cancer	2.32e-07	6.69e-06	CbGpPWpGaD
Irinotecan—ABCG2—Metabolism—AKT1—breast cancer	2.23e-07	6.44e-06	CbGpPWpGaD
Irinotecan—CYP3A7—Metabolism—AKT1—breast cancer	2.21e-07	6.38e-06	CbGpPWpGaD
Irinotecan—CYP3A4—Metabolism—CAV1—breast cancer	2.14e-07	6.17e-06	CbGpPWpGaD
Irinotecan—ABCB1—Metabolism—PTEN—breast cancer	2.09e-07	6.04e-06	CbGpPWpGaD
Irinotecan—CYP2B6—Metabolism—PIK3CA—breast cancer	2e-07	5.78e-06	CbGpPWpGaD
Irinotecan—CYP3A5—Metabolism—PIK3CA—breast cancer	1.96e-07	5.65e-06	CbGpPWpGaD
Irinotecan—CYP3A4—Metabolism—PIK3CG—breast cancer	1.95e-07	5.62e-06	CbGpPWpGaD
Irinotecan—CYP3A4—Metabolism—PIK3CD—breast cancer	1.71e-07	4.94e-06	CbGpPWpGaD
Irinotecan—CYP3A4—Metabolism—ALB—breast cancer	1.69e-07	4.88e-06	CbGpPWpGaD
Irinotecan—ALB—Metabolism—PIK3CA—breast cancer	1.69e-07	4.86e-06	CbGpPWpGaD
Irinotecan—CYP2B6—Metabolism—AKT1—breast cancer	1.64e-07	4.72e-06	CbGpPWpGaD
Irinotecan—CYP3A4—Metabolism—NOS3—breast cancer	1.62e-07	4.67e-06	CbGpPWpGaD
Irinotecan—CYP3A5—Metabolism—AKT1—breast cancer	1.6e-07	4.61e-06	CbGpPWpGaD
Irinotecan—CYP3A4—Metabolism—PIK3CB—breast cancer	1.49e-07	4.31e-06	CbGpPWpGaD
Irinotecan—CYP3A4—Metabolism—PTGS2—breast cancer	1.48e-07	4.27e-06	CbGpPWpGaD
Irinotecan—ABCB1—Metabolism—PIK3CA—breast cancer	1.48e-07	4.26e-06	CbGpPWpGaD
Irinotecan—ALB—Metabolism—AKT1—breast cancer	1.38e-07	3.97e-06	CbGpPWpGaD
Irinotecan—CYP3A4—Metabolism—PTEN—breast cancer	1.29e-07	3.72e-06	CbGpPWpGaD
Irinotecan—ABCB1—Metabolism—AKT1—breast cancer	1.21e-07	3.48e-06	CbGpPWpGaD
Irinotecan—CYP3A4—Metabolism—PIK3CA—breast cancer	9.1e-08	2.63e-06	CbGpPWpGaD
Irinotecan—CYP3A4—Metabolism—AKT1—breast cancer	7.43e-08	2.14e-06	CbGpPWpGaD
